The Minister said some poor countries are being supplied the vaccine on a grant basis while some nations wanted it on par with the price that the Indian government pays to the vaccine makers.
- India has so far supplied COVID- 19 vaccines to 15 countries and another 25 nations are in the queue at different levels for the jab, External Affairs Minister S. Jaishankar said in Amaravati on February 6.
- He said there are three categories of countries that are keen to get the vaccine from India — poor, price-sensitive nations and other countries which directly deal with pharmaceutical companies that make the antidote.
- The Centre has already given the nod for two COVID-19 vaccines — Covaxin of city-based Bharat Biotech and Covishield of Oxford, being manufactured by Serum Institute of India in Pune, which are being administered to frontline workers from January 16, under Emergency Use Authorisation.
- “In response to these requests, and in keeping with India’s stated commitment to using India’s vaccine production and delivery capacity to help all of the human fights the Covid pandemic, supplies under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar, and Seychelles will begin from 20 January 2021,” said the press communique.
- According to News 18, the Serum Institute of India has informed that it has 53 million doses in stock, out of which 25 million are for export. It has also provided more than 11 million doses to the Indian government so far. The MEA is also likely to get 810,000 doses of Bharat Biotech’s Covaxin vaccine by the end of this week.
Mr. Jaishankar said Prime Minister Narendra Modi’s idea was to establish the country as the “Pharmacy of the World”, taking advantage of the domestic capabilities and the way India emerged as IT leader during the Y2K issue.